Anti-Phospholipid Autoantibodies Bind to Apoptotic, but Not Viable, Thymocytes in a β2-Glycoprotein I-Dependent Manner

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2201-2208

  Price, Barbara E ^a   Rauch, Joyce ^b   Shia, Michael A ^a   Walsh, Mary T ^a   Lieberthal, Wilfred ^a   Gilligan, Hannah M ^a   O'Laughlin, Terry ^a   Koh, Jason S ^a   Levine, Jerrold S ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; BETA2 GLYCOPROTEIN 1; GLYCOPROTEIN; MEMBRANE ANTIGEN; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY;

ADSORPTION; ANIMAL; ANTIBODY AFFINITY; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; BLOOD; CBA MOUSE; CHEMISTRY; CYTOLOGY; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE; PHYSIOLOGY; STAINING; T LYMPHOCYTE; THYMUS;

ADSORPTION; ANIMALS; ANIONS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY AFFINITY; ANTIGENS, SURFACE; APOPTOSIS; BETA 2-GLYCOPROTEIN I; GLYCOPROTEINS; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PHOSPHOLIPIDS; STAINING AND LABELING; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0030240765     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. McNeil, H. P., C. N. Chesterman, and S. A. Krilis. 1991. Immunology and clinical importance of antiphospholipid antibodies. Adv. Immunol. 49:193.
2. Lockshin, M. D. 1994. Antiphospholipid antibody syndromes. Rheum. Dis. Clin. North Am. 20:45.
3. Khamashta, M. A., and G. R. V. Hughes. 1993. Detection and importance of anticardiolipin antibodies. J. Clin. Path. 46:104.
4. 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87:4120.
5. Matsuura, E., Y. Igarashi, M. Fujimoto, K. Ichikawa, T. Suzuki, T. Sumida, T. Yasuda, and T. Koike. 1992. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol. 148:3885.
6. 2-glycoprotein I. J. Clin. Invest. 90:1100.
7. Matsurra, E., Y. Igrashi, T. Yasuda, D. Triplett, and T. Koike. 1994. Anticardiolipin antibodies recognize beta-2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179:457.
8. 2-glycoprotein I. Proc. Natl. Acad. Sci. USA 81:3640.
9. 2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles. Int. J. Biochem. 16:511.
10. Gharavi, A. E., E. N. Harris, R. A. Asherson, and G. R. V. Hughes. 1987. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann. Rheum. Dis. 46:1.
11. Triplett, D. A., J. T. Brandt, K. A. Musgrave, and C. A. Orr. 1988. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 259:550.
12. 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb. Haemost. 68:297.
13. Rauch, J., M. Tannenbaum, and A. S. Janoff. 1989. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb. Haemost. 62:892.
14. Bevers, E. M., M. Galli, T. Barbui, P. Comfurius, and R. F. A. Zwaal. 1991. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb. Haemost. 66:629.
15. Sammaritano, L. R., A. E. Gharavi, C. Soberano, R. A. Levy, and M. D. Lockshin. 1992. Phospholipid binding of antiphospholipid antibodies and placental anticoagulant protein. J. Clin. Immunol. 12:27.
16. Hawthorne, J. N., and G. B. Ansell. 1982. Phospholipids. Elsevier Biomedical Press, Amsterdam, The Netherlands.
17. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148:2207.
18. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14:131.
19. Cohen, J. J., and R. C. Duke. 1984. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:38.
20. Sun, X.-M., R. T. Snowden, D. N. Skilleter, D. Dinsdale, M. G. Ormerod, and G. M. Cohen. 1992. A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Analyt. Biochem. 204:351.
21. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. G. Schaller, N. Talal, and R. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271.
22. Asherson, R. A. 1992. Antiphospholipid antibodies and syndromes. In Systemic Lupus Erythematosus. R. G. Lahita, ed. Churchill Livingstone, New York, p. 587.
23. Hazeltine, M., Rauch, J., Danoff, D., Esdaile, J., and H. Tannenbaum. 1988. Anti-phospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs and hypocomplemetemia. J. Rheumatol. 15:80.
24. Rauch, J., M. Tannenbaum, H. Tannenbaum, H. Ramelson, P. R. Cullis, C. P. S. Tilcock, M. J. Hope, and A. S. Janoff. 1986. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J. Biol. Chem. 261:9672.
25. 2-glycoprotein. I. Localization of the disulfide bridges. Biochemistry 31:3611.
26. Galli, M., and E. M. Bevers. 1995. Inhibition of phospholipid-dependent coagulation reactions by "antiphospholipid antibodies": possible modes of action. Lupus 3:223.
27. Xu, H., M. M. Frojmovic, T. Wong, and J. Rauch. 1995. p32, a platelet autoantigen recognized by an SLE-derived autoantibody that inhibits platelet aggregation. J. Autoimmun. 8:97.
28. Harlow, E., and D. Lane. 1988. Storing and purifying antibodies. In Antibodies: A Laboratory Manual. E. Harlow and D. Lane, eds. Cold Spring Harbor Laboratory. Cold Spring Harbor, NY, pp. 283-318.
29. Mower, D. A., D. W. Peckham, V. A. Illera, J. K. Fishbaugh, L. L. Stunz, and R. E. Ashman. 1994. Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis J. Immunol. 152:4832.
30. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179:1317.
31. Pierangeli, S. S., E. N. Harris, A. E. Gharavi, G. Goldsmith, D. W. Branch, and W. L. Dean. 1993. Are immunoglobulins with lupus anticoagulant activity specific for phospholipids? Br. J. Haematol. 85:124.
32. 2-glycoprotein I in the absence of phospholipid. J. Immunol. 154:954.
33. Koopman, G., C. P. M. Reutelingsperger, G. A. M. Kuijten, R. M. J. Keehnen, S. T. Pals, and M. H. J. van Oers. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415.
34. Price, B., W. Lieberthal, V. Triaca, J. Fitzpatrick, J. Koh, and J. Levine. 1994. The lupus anticoagulant recognizes an epitope on membranes of apoptotic cells. J. Am. Soc. Nephrol 5:763A (Abstr.).
35. Price, B., H. Gilligan, J. Koh, J. Rauch, and J. Levine. 1995. Apoptotic cells as the natural immunogen for antiphospholipid autoantibodies. J. Am. Soc. Nephrol. 6:849A (Abstr.).
36. Chonn, A., S. C. Semple, and P. R. Cullis. 1995. β2-Glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J. Biol. Chem. 270:25845.
37. Rauch, J., and A. S. Janoff. 1992. The nature of antiphospholipid antibodies. J. Rheumatol. 19:1782.
38. 2-glycoprotein I (apolipoprotein H) as cofactor. J. Rheumatol. 19:1397.
39. 2-glycoprotein I binding to cardiolipin results in conformational changes in both molecules by Fourier transform infra-red spectroscopy. Arthritis Rheum. 37:5280 (Abstr.).
40. Simantov, R., J. M. LaSala, S. K. Lo, A. E. Gharavi, L. R. Sammaritano, and J. E. Salmon. 1995. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest. 96:2211.
41. 2-Glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants. Blood 81:1255.
42. 2-glycoprotein I and through it that of IgG antiphospholipid antibodies: studies in platelets from patients with antiphospholipid syndrome and normal subjects. J. Autoimmun. 7:335.
43. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177:1367.
44. Bell, D. A., and B. Morrison. 1991. The spontaneous apoptotic cell death of normal human lymphocytes in vitro: The release of, and immunoproliferative response to, nucleosomes in vivo. Immunol. Immunopathol. 60:13.
45. Tan, E. M. 1994. Autoimmunity and apoptosis. J. Exp. Med. 179:1083.
46. Tax, W. J. M., C. Kramers, M. C. K. van Bruggen, and J. H. M. Berden. 1995. Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int. 48:666.
47. Bell, D. A., B. Morrison, and P. Vandenbygaart. 1990. Immunogenic DNA-related factors: nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85:1487.
48. Lieberthal, W., V. Triaca, and J. Levine. 1996. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am. J. Physiol. 270 (Renal Fluid Electrolyte Physiol. 39):F700.
49. Lieberthal, W., V. Triaca, B. Bredy, and J. Levine. 1994. Apoptosis of renal epithelial cells: Role of serum deprivation and oxidant injury. J. Am. Soc. Nephrol. 5:902A (Abstr.).